55. 再発性多発軟骨炎 ［臨床試験数：6，薬物数：7（DrugBank：7），標的遺伝子数：10，標的パスウェイ数：54］
Searched query = "Relapsing polychondritis"
The queries were searched in Public_title, Scientific_title, and Condition of the data. Export date: 11/20/2019, 11/21/2019. Trials are sorted by Date_enrolment from most recent to oldest in the table.
| No. | TrialID | Date_ enrollement | Last_Refreshed_ on | Public_title | Scientific_title | Condition | Intervention | Primary_ sponsor | Secondary_ sponsor | Recruitment_ Status | Inclusion_ agemin | Inclusion_ agemax | Inclusion_ gender | Target_ size | Phase | Countries |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | NCT04077736 | September 10, 2019 | 16 September 2019 | Low-dose Recombinant Human IL-2 for the Treatment of Relapsing Polychondritis | A Pilot Study of Low Dose IL-2 in the Treatment of Relapsing Polychondritis | Relapsing Polychondritis | Drug: Interleukin-2 | Peking University People's Hospital | Not recruiting | 18 Years | 70 Years | All | 10 | Phase 2 | ||
| 2 | JPRN-UMIN000006950 | 2011/12/01 | 2 April 2019 | Effects of additional inhaled tiotropium in relapsing polychondritis with airway involvement | Relapsing polychondritis | To record subjective symptoms, pulmonary function, airway diameter and dimension 3 months before, at baseline and 3 months following tiotropium | St. Marianna University School of Medicine Division of Respiratory and Infectious Diseases, Department of Internal Medicine | Not Recruiting | Not applicable | Not applicable | Male and Female | 20 | Not selected | Japan | ||
| 3 | NCT01272856 | January 2011 | 19 February 2015 | Study on the Safety of Abatacept in Relapsing Polychondritis | An Open-Label, Single-Center, Phase I Study on the Safety of Abatacept in Relapsing Polychondritis | Relapsing Polychondritis | Drug: Abatacept | Benaroya Research Institute | Bristol-Myers Squibb | Not recruiting | 18 Years | 80 Years | Both | 4 | Phase 1 | United States |
| 4 | JPRN-UMIN000003869 | 2010/07/01 | 2 April 2019 | A clinical study to establish in diagnostic criteria and treatment guideline of relapsing polychondritis. | Relapsing polychondritis | corticosteroid+methotrexate corticosteroid+ciclosporin | St. Marianna University School of Medicine | Recruiting | 20years-old | Not applicable | Male and Female | 30 | Not selected | Japan | ||
| 5 | NCT01104480 | May 2010 | 19 February 2015 | Tocilizumab for Relapsing Polychondritis | Efficacy of Tocilizumab in a Patient With Relapsing Polychondritis | Relapsing Polychondritis | Drug: Tocilizumab | McMaster Children's Hospital | Not recruiting | 12 Years | 15 Years | Male | 0 | Phase 2 | Canada | |
| No. | TrialID | Date_ enrollement | Last_Refreshed_ on | Public_title | Scientific_title | Condition | Intervention | Primary_ sponsor | Secondary_ sponsor | Recruitment_ Status | Inclusion_ agemin | Inclusion_ agemax | Inclusion_ gender | Target_ size | Phase | Countries |
| 6 | NCT01041248 | January 2010 | 19 February 2015 | Single Patient Study to Treat Relapsing Polychondritis With Tocilizumab | Efficacy of Tocilizumab in a Patient With Relapsing Polychondritis | Relapsing Polychondritis | Drug: Tocilizumab | Children's Hospital of Eastern Ontario | Not recruiting | N/A | N/A | Male | 1 | N/A | Canada |